Bert Schepens

4.8k total citations · 1 hit paper
56 papers, 2.9k citations indexed

About

Bert Schepens is a scholar working on Epidemiology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Bert Schepens has authored 56 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Epidemiology, 28 papers in Immunology and 17 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Bert Schepens's work include Influenza Virus Research Studies (28 papers), Respiratory viral infections research (20 papers) and Monoclonal and Polyclonal Antibodies Research (17 papers). Bert Schepens is often cited by papers focused on Influenza Virus Research Studies (28 papers), Respiratory viral infections research (20 papers) and Monoclonal and Polyclonal Antibodies Research (17 papers). Bert Schepens collaborates with scholars based in Belgium, United States and Netherlands. Bert Schepens's co-authors include Xavier Saelens, Walter Fiers, Kenny Roose, Michael Schotsaert, Dorien De Vlieger, Lorena Itatí Ibañez, Marina De Filette, Eef Parthoens, Jason S. McLellan and Iebe Rossey and has published in prestigious journals such as Cell, Nucleic Acids Research and Nature Communications.

In The Last Decade

Bert Schepens

56 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies

2020 387 citations Daniel Wrapp, Dorien De Vlieger et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bert Schepens Belgium	30	1.3k	963	903	881	753	56	2.9k
John de Kruif Netherlands	26	767 0.6×	1.3k 1.3×	939 1.0×	699 0.8×	1.3k 1.7×	42	3.2k
Chih‐Jen Wei United States	26	2.3k 1.7×	1.3k 1.3×	1.2k 1.3×	1.3k 1.5×	417 0.6×	35	3.9k
Mark Throsby Netherlands	23	1.5k 1.1×	871 0.9×	774 0.9×	985 1.1×	813 1.1×	46	3.3k
Surender Khurana United States	34	2.3k 1.7×	702 0.7×	1.4k 1.5×	1.4k 1.5×	504 0.7×	93	3.7k
Gunilla B. Karlsson Hedestam Sweden	37	656 0.5×	1.2k 1.2×	1.1k 1.2×	2.1k 2.4×	602 0.8×	113	4.0k
Ryan McBride United States	40	2.4k 1.8×	2.1k 2.2×	1.1k 1.2×	1.2k 1.4×	591 0.8×	79	4.6k
Peter Vanlandschoot Belgium	22	1.1k 0.8×	696 0.7×	407 0.5×	804 0.9×	686 0.9×	44	2.1k
Gerald Nakamura United States	30	880 0.7×	1.3k 1.4×	817 0.9×	1.2k 1.4×	798 1.1×	45	3.6k
Pavlo Gilchuk United States	21	670 0.5×	631 0.7×	1.4k 1.5×	807 0.9×	397 0.5×	49	2.4k
Celia C. LaBranche United States	33	881 0.7×	1.2k 1.3×	1.3k 1.4×	1.8k 2.0×	629 0.8×	149	3.9k

Countries citing papers authored by Bert Schepens

Since Specialization

Citations

This map shows the geographic impact of Bert Schepens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bert Schepens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bert Schepens more than expected).

Fields of papers citing papers by Bert Schepens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bert Schepens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bert Schepens. The network helps show where Bert Schepens may publish in the future.

Co-authorship network of co-authors of Bert Schepens

This figure shows the co-authorship network connecting the top 25 collaborators of Bert Schepens. A scholar is included among the top collaborators of Bert Schepens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bert Schepens. Bert Schepens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schie, Loes van, Wander Van Breedam, Bert Schepens, et al.. (2023). GlycoVHH: optimal sites for introducing N-glycans on the camelid VHH antibody scaffold and use for macrophage delivery. mAbs. 15(1). 2210709–2210709. 6 indexed citations

Rossey, Iebe, et al.. (2022). How RSV Proteins Join Forces to Overcome the Host Innate Immune Response. Viruses. 14(2). 419–419. 27 indexed citations

Rossey, Iebe, Ching‐Lin Hsieh, Koen Sedeyn, et al.. (2021). A Vulnerable, Membrane-Proximal Site in Human Respiratory Syncytial Virus F Revealed by a Prefusion-Specific Single-Domain Antibody. Journal of Virology. 95(11). 12 indexed citations

Hoecke, Silvie Van den, Marlies Ballegeer, Bram Vrancken, et al.. (2021). In Vivo Therapy with M2e-Specific IgG Selects for an Influenza A Virus Mutant with Delayed Matrix Protein 2 Expression. mBio. 12(4). e0074521–e0074521. 6 indexed citations

Wrapp, Daniel, Dorien De Vlieger, Kizzmekia S. Corbett, et al.. (2020). Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies. Cell. 181(5). 1004–1015.e15. 387 indexed citations breakdown →

Hoecke, Lien Van, Rein Verbeke, Dorien De Vlieger, et al.. (2020). mRNA Encoding a Bispecific Single Domain Antibody Construct Protects against Influenza A Virus Infection in Mice. Molecular Therapy — Nucleic Acids. 20. 777–787. 29 indexed citations

Kolpe, Annasaheb, Maria Romero, Bert Schepens, et al.. (2019). Super-resolution microscopy reveals significant impact of M2e-specific monoclonal antibodies on influenza A virus filament formation at the host cell surface. Scientific Reports. 9(1). 4450–4450. 16 indexed citations

Sedeyn, Koen, Bert Schepens, & Xavier Saelens. (2019). Respiratory syncytial virus nonstructural proteins 1 and 2: Exceptional disrupters of innate immune responses. PLoS Pathogens. 15(10). e1007984–e1007984. 54 indexed citations

Pintelon, Isabel, Kenny Roose, Bert Schepens, et al.. (2018). Removal of the N-Glycosylation Sequon at Position N116 Located in p27 of the Respiratory Syncytial Virus Fusion Protein Elicits Enhanced Antibody Responses after DNA Immunization. Viruses. 10(8). 426–426. 18 indexed citations

10.

Nuhn, Lutz, Lien Van Hoecke, Kim Deswarte, et al.. (2018). Potent anti-viral vaccine adjuvant based on pH-degradable nanogels with covalently linked small molecule imidazoquinoline TLR7/8 agonist. Biomaterials. 178. 643–651. 45 indexed citations

11.

Kolpe, Annasaheb, Bert Schepens, Liang Ye, Peter Staeheli, & Xavier Saelens. (2018). Passively transferred M2e-specific monoclonal antibody reduces influenza A virus transmission in mice. Antiviral Research. 158. 244–254. 18 indexed citations

12.

Rossey, Iebe, Morgan S. A. Gilman, Stephanie Kabeche, et al.. (2017). Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state. Nature Communications. 8(1). 16165–16165. 70 indexed citations

13.

Roose, Kenny, Anouk Smet, Bert Schepens, et al.. (2017). Bispecific T cell engaging antibody constructs targeting a universally conserved part of the viral M2 ectodomain cure and prevent influenza A virus infection. Antiviral Research. 141. 155–164. 15 indexed citations

14.

Schotsaert, Michael, Tine Ysenbaert, Anouk Smet, et al.. (2016). Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategies. Scientific Reports. 6(1). 24402–24402. 47 indexed citations

15.

Söderholm, Sandra, Denis E. Kainov, Tiina Öhman, et al.. (2016). Phosphoproteomics to Characterize Host Response During Influenza A Virus Infection of Human Macrophages. Molecular & Cellular Proteomics. 15(10). 3203–3219. 57 indexed citations

16.

Verhelst, Judith, Silvie Van den Hoecke, Anouk Smet, et al.. (2015). A GFP Expressing Influenza A Virus to Report In Vivo Tropism and Protection by a Matrix Protein 2 Ectodomain-Specific Monoclonal Antibody. PLoS ONE. 10(3). e0121491–e0121491. 20 indexed citations

17.

Roose, Kenny, et al.. (2013). Hepatitis B core–based virus–like particles to present heterologous epitopes. Expert Review of Vaccines. 12(2). 183–198. 57 indexed citations

18.

Ibañez, Lorena Itatí, Kenny Roose, Marina De Filette, et al.. (2013). M2e-Displaying Virus-Like Particles with Associated RNA Promote T Helper 1 Type Adaptive Immunity against Influenza A. PLoS ONE. 8(3). e59081–e59081. 41 indexed citations

19.

Schepens, Bert, Lorena Itatí Ibañez, Anna Hultberg, et al.. (2011). Nanobodies® Specific for Respiratory Syncytial Virus Fusion Protein Protect Against Infection by Inhibition of Fusion. The Journal of Infectious Diseases. 204(11). 1692–1701. 43 indexed citations

20.

Fiers, Walter, Marina De Filette, Karim El Bakkouri, et al.. (2009). M2e-based universal influenza A vaccine. Vaccine. 27(45). 6280–6283. 289 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact